# CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9

> **NCT03862794** · NA · COMPLETED · sponsor: **Public Health England** · enrollment: 7000 (actual)

## Conditions studied

- Prescribing, Off-Label

## Interventions

- **BEHAVIORAL:** new social norm feedback letter with bar chart
- **BEHAVIORAL:** standard social norm feedback letter

## Key facts

- **NCT ID:** NCT03862794
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-05-30
- **Target enrollment:** 7000 (ACTUAL)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03862794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03862794, "CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03862794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*